Targeted antipeptide antibodies to cytochrome P450 2C18 based on epitope mapping of an inhibitory monoclonal antibody to P450 2C5

Archives of Biochemistry and Biophysics

Volumn 338, Issue 2, 1997, Pages 157-164

  Richardson, Toby H ^a   Griffin, Keith J ^a   Jung, Frank ^a   Raucy, Judy L ^b   Johnson, Eric F ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b AGOURON PHARMACEUTICALS INC   (United States)

Author keywords

2C18, and 2C19; 2C9; 2F5; epitope mapping; immunoquantitation; P450s 2C8

Indexed keywords

ANTIGEN; CYTOCHROME P450; DIAZEPAM; HYBRID PROTEIN; MONOCLONAL ANTIBODY; PROGESTERONE; PROTEIN ANTIBODY;

AMINO ACID SUBSTITUTION; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIGEN RECOGNITION; ARTICLE; EPITOPE MAPPING; HUMAN; IMMUNOBLOTTING; IMMUNOREACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROGESTERONE METABOLISM; PROTEIN EXPRESSION; QUANTITATIVE ASSAY;

EID: 0031568856     PISSN: 00039861     EISSN: None     Source Type: Journal    
DOI: 10.1006/abbi.1996.9817     Document Type: Article

References (39)

1. Kronbach T., Johnson E. F. J. Biol. Chem. 266:1991;6215-6220.
2. Manns M. P., Griffin K. J., Sullivan K. F., Johnson E. F. J. Clin. Invest. 88:1991;1370-1378.
3. Edwards R. J., Sesardic D., Murray B. P., Singleton A. M., Davies D. S., Boobis A. R. Biochem. Pharmacol. 43:1992;1737-1746.
4. Edwards R. J., Murray B. P., Murray S., Singleton A. M., Davies D. S., Boobis A. R. Biochim. Biophys. Acta. 1161:1993;38-46.
5. Soucek P., Martin M. V., Ueng Y. F., Guengerich F. P. Biochemistry. 34:1995;16,013-16,021.
6. Leeder J. S., Gaedigk A., Lu X. L., Cook V. A. Mol. Pharmacol. 49:1996;234-243.
7. Frey A. B., Waxman D. J., Kreibich G. J. Biol. Chem. 260:1985;15,253-15,265.
8. Shen S., Strobel H. W. Arch. Biochem. Biophys. 320:1995;162-169.
9. Charnecki J., Putt D., Kim E. Y., Kim H. Biochem. Biophys. Res. Commun. 216:1995;1024-1033.
10. Edwards R. J., Singleton A. M., Murray B. P., Sesardic D., Rich K. J., Davies D. S., Boobis A. R. Biochem. J. 266:1990;497-504.
11. Edwards R. J., Singleton A. M., Murray B. P., Murray S., Boobis A. R., Davies D. S. Biochem. J. 278:1991;749-757.
12. Nakamura A., Yamamoto Y., Tasaki T., Sugimoto C., Masuda M., Kazusaka A., Fujita S. Xenobiotica. 25:1995;1103-1109.
13. Cribb A., Nuss C., Wang R. Drug Metab. Dispos. 23:1995;671-675.
14. Reubi I., Griffin K. J., Raucy J. L., Johnson E. F. J. Biol. Chem. 259:1984;5887-5892.
15. Richardson T. H., Hsu M., Kronbach T., Barnes H. J., Chan G., Waterman M. R., Kemper B., Johnson E. F. Arch. Biochem. Biophys. 300:1993;510-516.
16. Sanger F., Coulson A. R., Barrell B. G., Smith A. J. H., Roe B. A. J. Mol. Biol. 143:1980;161-178.
17. Landt O., Grunert H.-P., Hahn U. Gene. 96:1990;125-128.
18. Hsu M.-H., Griffin K. J., Wang Y., Kemper B., Johnson E. F. J. Biol. Chem. 268:1993;6939-6944.
19. Harlow E., Lane D. Antibodies: A Laboratory Manual. 1988;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
20. Leo M. A., Iida S., Lieber C. S. Arch. Biochem. Biophys. 234:1984;305-312.
21. Goldstein J. A., Faletto M. B., Romkes-Sparks M., Sullivan T., Kitareewan S., Raucy J. L., Lasker J. M., Ghanayem B. I. Biochemistry. 33:1994;1743-1752.
22. Raucy J. L., Lasker J. M. Methods Enzymol. 206:1991;577-587.
23. Dieter H. H., Johnson E. F. J. Biol. Chem. 257:1982;9315-9323.
24. Laemmli U. K. Nature. 227:1970;680-685.
25. Towbin H., Theophil S., Gordon J. Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.
26. Kronbach T., Kemper B., Johnson E. F. Current Research in Protein Chemistry: Techniques, Structure, and Function. 1990;Academic Press, San Diego. p. 481-488.
27. Richardson T. H., Jung F., Griffin K. J., Wester M., Raucy J. L., Kemper B., Bornheim L. M., Hassett C., Omiecinski C. J., Johnson E. F. Arch. Biochem. Biophys. 323:1995;87-96.
28. Hasemann C. A., Kurumbail R. G., Boddupalli S. S., Peterson J. A., Deisenhofer J. Structure. 3:1995;41-62.
29. Yamamoto A. M., Cresteil D., Boniface O., Clerc F. F., Alvarez F. Eur. J. Immunol. 23:1993;1105-1111.
30. Duclos-Vallée J.-C., Hajoui O., Yamamoto A. M., Jacqz-Aigrain E., Alvarez F. Gastroenterology. 108:1995;470-476.
31. Nakamura A., Yamamoto Y., Tasaki T., Sugimoto C., Masuda M., Kazusaka A., Fujita S. Drug Metab. Dispos. 23:1995;1268-1273.
32. Shen S., Strobel H. W. Arch. Biochem. Biophys. 294:1992;83-90.
33. Shen S., Strobel H. W. Arch. Biochem. Biophys. 304:1993;257-265.
34. Komai K., Sumida K., Haneko H., Nakatsuka I. Pharmacogenetics. 6:1996;117-119.
35. Wrighton S. A., Thomas P. E., Willis P., Maines S. L., Watkins P. B., Levin W., Guzelian P. S. J. Clin. Invest. 80:1987;1017-1022.
36. Wrighton S. A., Stevens J. C., Becker G. W., Vandenbranden M. Arch. Biochem. Biophys. 306:1993;240-245.
37. De Morais S. M. F., Wilkinson G. R., Blaisdell J., Nakamura K., Meyer U. A., Goldstein J. A. J. Biol. Chem. 269:1994;15,419-15,422.
38. De Morais S. M. F., Wilkinson G. R., Blaisdell J., Meyer U. A., Nakamura K., Goldstein J. A. Mol. Pharmacol. 46:1994;594-598.
39. Nelson D. R., Koymans L., Kamataki T., Stegeman J. J., Feyereisen R., Waxman D. J., Waterman M. R., Gotoh O., Coon M. J., Estabrook R. W., Gunsalus I. C., Nebert D. W. Pharmacogenetics. 6:1996;1-42.